about
Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in miceComplete Freund's adjuvant induces experimental autoimmune myocarditis by enhancing IL-6 production during initiation of the immune responseT cells contribute to disease severity during coxsackievirus B4 infection.Interferon regulatory factor 3 is required for viral induction of beta interferon in primary cardiac myocyte culturesGender influences herpes simplex virus type 1 infection in normal and gamma interferon-mutant miceToward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.An aged host promotes the evolution of avirulent coxsackievirus into a virulent strain.Protection against experimental autoimmune myocarditis is mediated by interleukin-10-producing T cells that are controlled by dendritic cellsAlterations in major histocompatibility complex association of myocarditis induced by coxsackievirus B3 mutants selected with monoclonal antibodies to group A streptococciEvaluation of coxsackievirus infection in children with human immunodeficiency virus type 1-associated cardiomyopathyThe cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region.Reovirus-induced acute myocarditis in mice correlates with viral RNA synthesis rather than generation of infectious virus in cardiac myocytes.Extracellular matrix remodelling after coxsackievirus B3-induced murine myocarditis.Autoimmunity and coxsackievirus infection in primary Sjogren's syndrome.Nucleic acid detection systems for enteroviruses.Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3Multiple viral core proteins are determinants of reovirus-induced acute myocarditis.Lymphocytes protect against and are not required for reovirus-induced myocarditis.T cells expressing the gamma delta T-cell receptor potentiate coxsackievirus B3-induced myocarditisOngoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammationCytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin.Persistent viral infection in primary Sjogren's syndrome: review and perspectives.Nitric oxide inhibition of coxsackievirus replication in vitro.Induction of a broad spectrum of inflammation-related genes by Coxsackievirus B3 requires Interleukin-1 signaling.Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2.Cytopathogenic effect in cardiac myocytes but not in cardiac fibroblasts is correlated with reovirus-induced acute myocarditis.Expressions of CD11a, CD11b, and CD11c integrin proteins in rats with myocardial hypertrophy.Demonstration of Coxsackie virus RNA in formalin-fixed tissue sections from childhood myocarditis cases by in situ hybridization and the polymerase chain reaction.
P2860
Q24804882-0622B38B-A8D2-4407-ABEA-0D0F215973B8Q33638740-502525A3-1F97-4C75-87BC-36A6A38016B4Q33644332-A74E9EBE-E5D0-4F75-8D09-54CF82869FC3Q33825249-217BF3A8-647D-47BF-B402-CE7DD09BC92EQ33866427-56232BF9-44FA-444C-B3FD-954110871D84Q34359584-27199AD6-6174-46FF-A9A6-B51508B3331BQ35025154-7943A2D6-6438-4D0B-B9C1-7E9D7876EFFAQ35084902-33D1B4E6-3F7B-47B7-9DD7-820EDEA0EC74Q35485479-C37D4FDA-873B-4405-9F0A-3746C9BCC256Q35578679-9D07981C-586C-4578-8F4B-3A34366AD190Q35843889-ED821214-193F-4E3F-A42B-77D14D72624FQ35869765-71EE2D88-5C9F-4EA5-8433-14AD91AFC33AQ36028718-F7D9C13A-993A-4201-8588-DB47FE5EBA92Q36193100-66727661-8494-4D00-B823-B0229BC647F3Q36401640-32B3352F-5C29-4C11-B52F-AFE56B70BF0FQ36625352-100F9171-2BB9-4CA1-8299-E2DF94574F74Q36638386-785D0D59-5FBB-4B36-B739-13BE7819C645Q36653708-7D303240-DAFC-452E-8FA2-5F7B56F32914Q36685183-2E0C8452-D63C-4644-94E7-F941FD40456CQ36771022-EA217B1D-0EFA-4CF9-92A9-2D4670E884A6Q36833115-38D50634-7DB5-4D48-BE67-757C35074828Q36997257-53713B1E-6050-461C-BDC7-5022994B905CQ37372893-356FCD1E-C6BE-4C04-B4D1-1F195277E563Q39337854-0B07645F-4E0C-4CE5-B409-C73D96C2A633Q40037798-588D2B9E-CD8D-4E26-BF5B-7EF6A9D53715Q40047678-3D10CF9E-7095-493F-8688-A406646002BEQ41406042-58EE627C-9527-44AC-81CE-F32FD0EB8AEFQ45776421-ADF2E413-F162-45BA-8E5C-EA70FCEA68E7
P2860
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Clinical and experimental aspects of viral myocarditis.
@ast
Clinical and experimental aspects of viral myocarditis.
@en
type
label
Clinical and experimental aspects of viral myocarditis.
@ast
Clinical and experimental aspects of viral myocarditis.
@en
prefLabel
Clinical and experimental aspects of viral myocarditis.
@ast
Clinical and experimental aspects of viral myocarditis.
@en
P2093
P2860
P356
P1476
Clinical and experimental aspects of viral myocarditis.
@en
P2093
P2860
P304
P356
10.1128/CMR.2.2.191
P407
P577
1989-04-01T00:00:00Z